Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: August 2014
-
August 13-15, 2014 – Advanced Patent Law Seminars (Chisum Patent Academy) - Seattle, WA August 18-19, 2014 - Advanced Patent Prosecution Workshop 2014: Claim Drafting & Amendment Writing (Practising Law Institute) – San Francisco, CA August 18-20, 2014 – Advanced Patent Law Seminars (Chisum Patent Academy) - Seattle, WA August 19, 2014 – "Alice Corp. v. CLS Bank International:…
-
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar entitled "USPTO Guidance for Determining Subject Matter Eligibility In View of U.S. Supreme Court's Mayo and Myriad Decisions" on October 2, 2014 from 10:00 am to 11:15 am (CT). Patent Docs authors and MBHB attorneys Donald L. Zuhn, Jr., Ph.D. and Kevin E.…
-
By Shelley Rowland* and Katherine Hebditch** — After a protracted gestation period, the New Zealand's Patents Act 2013 will take full effect on 13 September 2014. The new Act represents the first major refresh of New Zealand's patent legislation in 60 years, and brings New Zealand patent law into line with most other countries around…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Medicines Company v. Accord Healthcare, Inc. et al.1:14-cv-00626; filed July 24, 2014 in the Middle District of North Carolina • Plaintiff: The Medicines Company• Defendants: Accord Healthcare, Inc.; Intas Pharmaceuticals Ltd. Infringement of U.S.…
-
By Donald Zuhn — On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (or "Myriad-Mayo Guidance") to implement a new procedure for determining the subject matter eligibility of claims under 35…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Roche Molecular Systems, Inc. v. Cepheid3:14-cv-03228; filed July 16, 2014 in the Northern District of California Infringement of U.S. Patent No. 5,643,723 ("Detection of a Genetic Locus Encoding Resistance to Rifampin in Mycobacterial Cultures…
-
The ABA Journal has begun work on its 8th annual list of the 100 best legal blogs (or blawgs) and has announced that it is seeking the advice of its readers, via the ABAJournal.com website, on which blogs to include on this year's Blawg 100. For the past two years, Patent Docs has been honored…
-
By Kevin E. Noonan — "The more things change . . ." is the beginning of an old saw, and that saying has particular relevance just days after the USPTO stopped accepted comments on its Subject Matter Eligibility Guidance. After all, this isn't the first time the Patent Office pendulum has swung against patenting (Don…
-
August 7, 2014 – "Battling Patent Trolls: Leveraging AIA, State and Federal Legislative Action, and Other Key Developments" (Strafford) – 1:00 to 2:30 pm (EDT) August 7, 2014 – "Divided Infringement in the Life Sciences: Implications of Limelight v. Akamai" (Intellectual Property Owners Association) – 2:00 to 3:00 pm (ET) August 13-15, 2014 – Advanced…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Divided Infringement in the Life Sciences: Implications of Limelight v. Akamai " on August 7, 2014 beginning at 2:00 pm (ET). Ned Israelsen of Knobbe, Martens, Olson & Bear, LLP; Jonathan Singer of Fish & Richardson, PC; and Mark Stewart of Eli Lilly…
Patent Docs 